InSysBio to participate in Biomarkers for Alzheimer’s Disease Summit

events
Conference
August 6, 2021

August 6, 2021

InSysBio will take part in Annual Biomarkers for Alzheimer’s Disease Summit, Digital Event which is going to be held August 24-26, 2021. InSysBio will present its Neurodegeneration modeling issues and Alzheimer’s Disease Platform update at its Virtual Booth!
Moreover, Tatiana Karelina, Head of Neurodegenerative Diseases Modeling Team, will give a talk on the topic “Mechanistic modeling approach to prediction and analysis of clinical trial results in neurodegeneration area”.

Tatiana is going to shed the light on the following points:

  • Quantitative system pharmacology (QSP) modeling of clinical trials facilitates interpretation of information provided by biomarkers.
  • QSP methods allows for investigation of interaction between pathological mechanisms, biomarkers and treatment: example for aducanumab clinical trial.
  • Combinatorial therapy efficacy on endpoints, intrinsic mechanisms and biomarkers can be potentially predicted by QSP.

10:35 EDT | 07:35 PDT on Wednesday, August 25.

Visit our Virtual Booth and follow our speaker!

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 120 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

March 2017
MoTuWeThFrSaSu
  
1
2
3
4
5
6
7
8
9
1. 09 Mar 2017 14:10 ISBM Enclosed Conference was held 20-22 February 2017 the 10th ISBM Enclosed Conference was held. For ten years the employees annually have been meeting together to share their scientific results and talk over future plans. ISBM did a great job in this working year.
10
11
12
13
14
15
1. 15 Mar 2017 11:49 Institute for Systems Biology participates in American Society for Clinical Pharmacology and Therapeutics 2017 Meeting Institute for Systems Biology Moscow – a company, providing modeling services for innovative drug design, announced participation in ASCPT 2017 Meeting, which is held on 15-18 March in Washington, DC. ISBM will present several studies and demonstrate an updated version of platform for quantitative systems pharmacology modeling of immune response - Immune Response Template (IRT).
16
17
18
19
20
21
22
23
24
25
26
27
28
1. 28 Mar 2017 17:56 Not all therapies are effective: Institute for Systems Biology Moscow to present the results of the Alzheimer’s disease Systems Pharmacology Modeling Moscow, Russia – March 28, 2017. On the 1st April, Tatyana Karelina, ISBM leading specialist in neurodegenerative field, will present a poster entitled "Amyloid toxicity and different mechanisms of action for amyloid-targeted treatments studied by quantitative systems pharmacology model" at the 13th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders to be held on March 29 - April 2, Vienna, Austria.
29
30
31
  
Upcoming Events
Tags
Latest News
29.10
InSysBio to announce its collaboration with BeOne Medicines
16.10
InSysBio to introduce a new data annotation service available in CYTOCON DB and fIVE DB
19.08
InSysBio to publish the new article "Revolutionizing drug discovery: Integrating artificial intelligence with quantitative systems pharmacology"
05.08
InSysBio to launch Immune Response Template Open for QSP modeling
25.06
InSysBio to announce extension of collaboration with discoveric bio alpha